about
Outcomes of liver transplantation for porto-pulmonary hypertension in model for end-stage liver disease eraSerum sodium and survival benefit of liver transplantationImpact of MELD-based allocation on end-stage renal disease after liver transplantation.Decision support for organ offers in liver transplantation.How can we define expanded criteria for liver donors?Liver transplantation for status 1: the consequences of good intentions.Patterns of Early Allograft Dysfunction in Adult Live Donor Liver Transplantation: The A2ALL Experience.Patient-specific prediction of ESRD after liver transplantation.National assessment of early hospitalization after liver transplantation: Risk factors and association with patient survival.National Assessment of Hospitalization Rates for Incident End-Stage Renal Disease After Liver TransplantationRecurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients.Donor factors similarly impact survival outcome after liver transplantation in hepatocellular carcinoma and non-hepatocellular carcinoma patients.Hepatic Hemodynamics and Portal Flow Modulation: The A2ALL Experience.Characteristics associated with liver graft failure: the concept of a donor risk index.Biliary reconstructive techniques and associated anatomic variants in adult living donor liver transplantations: The adult-to-adult living donor liver transplantation cohort study experience.Donation after cardiac death as a strategy to increase deceased donor liver availability.Estimating the effect of a rare time-dependent treatment on the recurrent event rate.The survival benefit of deceased donor liver transplantation as a function of candidate disease severity and donor qualityPredicted lifetimes for adult and pediatric split liver versus adult whole liver transplant recipientsLiver and intestine transplantation: summary analysis, 1994-2003Donation after cardiac death liver transplantation: predictors of outcomeKidney transplant graft outcomes in 379 257 recipients on 3 continentsSatisfaction with life and depressive symptoms in living organ donors and non-donors: New insights from the National Living Donor Assistance Center
P50
Q33992216-9AA20F10-2A12-4C36-BFB2-4EF3DD5EEA8AQ35162774-DB9D3079-2F9D-4ACD-9FD8-2540A6C6B7B6Q35465299-94BE84D5-306E-4921-A969-9166DD83E969Q36554175-2B017535-AC5A-4195-94E2-CDEA20AAA54EQ36564353-C4F8A73D-37DC-4954-9285-51E16A9A136AQ36801201-F979E866-E8BF-409E-A5A3-D81742D395D1Q37090275-8B5A0AE5-3666-424C-A599-03758302FB70Q37340234-60467E3F-A8BD-471C-BA60-B9857CF5ECA5Q38688657-83BD76C7-3A02-48A9-BAFB-96875247CE71Q39550629-1436DFCC-6D08-48A3-8BEF-3FD6E4A3F35AQ40638450-0D613144-B27D-4127-A291-9650D258D5A1Q44653651-1B0C530E-887A-4F24-B0B1-25E194A9BBA4Q45059270-0377CFC1-A855-4FEF-B947-2B7982E4D516Q46734908-F6AE50DF-69D2-4299-B1A9-2C3459DE7D67Q47961983-625A8497-C162-4D41-9E89-130A25CDEC68Q48414198-BA148D12-46BF-4700-A9CC-5D48A4EFACBEQ52685814-610F268F-29C0-43C5-B376-B3EF9C50B8CAQ80482509-52B47B2C-83CF-4D88-AC5B-EBC0519C7AF8Q80845739-7793A79F-FEBE-41D1-813B-6F63E5D1AA91Q81507609-2DC2E1BF-B3BB-4C79-9A28-A530BA9A31A6Q82065006-70059633-D7DB-48B9-ADD3-0BBD9A421980Q88156444-E2981DA5-1831-4521-84C0-51211E4B5717Q89776384-712B98EF-017D-4668-8C33-45441B60893A
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Nathan P Goodrich
@en
Nathan P Goodrich
@nl
type
label
Nathan P Goodrich
@en
Nathan P Goodrich
@nl
prefLabel
Nathan P Goodrich
@en
Nathan P Goodrich
@nl
P31
P496
0000-0003-0392-7146